Prediction of long-term benefits of inhaled steroids by phenotypic markers in moderateto-severe COPD: A randomized controlled trial

10.1371/journal.pone.0143793

Saved in:

Bibliographic Details
Main Authors:	Snoeck-Stroband J.B., Lapperre T.S., Sterk P.J., Hiemstra P.S., Thiadens H.A., Boezen H.M., Ten Hacken N.H.T., Kerstjens H.A.M., Postma D.S., Timens W., Sont J.K.
Other Authors:	DUKE-NUS MEDICAL SCHOOL
Format:	Article
Published:	Public Library of Science 2020
Subjects:	fluticasone propionate placebo bronchodilating agent corticosteroid fluticasone adult aged Article cell count chronic obstructive lung disease clinical effectiveness controlled study disease severity double blind procedure drug efficacy dyspnea female forced expiratory volume health status human inflammatory cell lung diffusion capacity major clinical study male multicenter study phenotype prediction randomized controlled trial smoking treatment duration treatment outcome clinical trial drug administration inhalational drug administration lung middle aged pathology pathophysiology physiology placebo effect Pulmonary Disease, Chronic Obstructive severity of illness index spirometry sputum Administration, Inhalation Adrenal Cortex Hormones Aged Bronchodilator Agents Drug Administration Schedule Female Fluticasone Forced Expiratory Volume Humans Lung Male Middle Aged Phenotype Placebo Effect Severity of Illness Index Spirometry Sputum Treatment Outcome
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/165757
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-165757
record_format	dspace
spelling	sg-nus-scholar.10635-1657572023-10-31T20:29:38Z Prediction of long-term benefits of inhaled steroids by phenotypic markers in moderateto-severe COPD: A randomized controlled trial Snoeck-Stroband J.B. Lapperre T.S. Sterk P.J. Hiemstra P.S. Thiadens H.A. Boezen H.M. Ten Hacken N.H.T. Kerstjens H.A.M. Postma D.S. Timens W. Sont J.K. DUKE-NUS MEDICAL SCHOOL fluticasone propionate placebo bronchodilating agent corticosteroid fluticasone adult aged Article cell count chronic obstructive lung disease clinical effectiveness controlled study disease severity double blind procedure drug efficacy dyspnea female forced expiratory volume health status human inflammatory cell lung diffusion capacity major clinical study male multicenter study phenotype prediction randomized controlled trial smoking treatment duration treatment outcome clinical trial drug administration inhalational drug administration lung middle aged pathology pathophysiology physiology placebo effect Pulmonary Disease, Chronic Obstructive severity of illness index spirometry sputum Administration, Inhalation Adrenal Cortex Hormones Aged Bronchodilator Agents Drug Administration Schedule Female Fluticasone Forced Expiratory Volume Humans Lung Male Middle Aged Phenotype Placebo Effect Pulmonary Disease, Chronic Obstructive Severity of Illness Index Spirometry Sputum Treatment Outcome 10.1371/journal.pone.0143793 PLoS ONE 10 12 143793 2020-03-19T07:50:22Z 2020-03-19T07:50:22Z 2015 Article Snoeck-Stroband J.B., Lapperre T.S., Sterk P.J., Hiemstra P.S., Thiadens H.A., Boezen H.M., Ten Hacken N.H.T., Kerstjens H.A.M., Postma D.S., Timens W., Sont J.K. (2015). Prediction of long-term benefits of inhaled steroids by phenotypic markers in moderateto-severe COPD: A randomized controlled trial. PLoS ONE 10 (12) : 143793. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0143793 19326203 https://scholarbank.nus.edu.sg/handle/10635/165757 Public Library of Science Unpaywall 20200320
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	fluticasone propionate placebo bronchodilating agent corticosteroid fluticasone adult aged Article cell count chronic obstructive lung disease clinical effectiveness controlled study disease severity double blind procedure drug efficacy dyspnea female forced expiratory volume health status human inflammatory cell lung diffusion capacity major clinical study male multicenter study phenotype prediction randomized controlled trial smoking treatment duration treatment outcome clinical trial drug administration inhalational drug administration lung middle aged pathology pathophysiology physiology placebo effect Pulmonary Disease, Chronic Obstructive severity of illness index spirometry sputum Administration, Inhalation Adrenal Cortex Hormones Aged Bronchodilator Agents Drug Administration Schedule Female Fluticasone Forced Expiratory Volume Humans Lung Male Middle Aged Phenotype Placebo Effect Pulmonary Disease, Chronic Obstructive Severity of Illness Index Spirometry Sputum Treatment Outcome
spellingShingle	fluticasone propionate placebo bronchodilating agent corticosteroid fluticasone adult aged Article cell count chronic obstructive lung disease clinical effectiveness controlled study disease severity double blind procedure drug efficacy dyspnea female forced expiratory volume health status human inflammatory cell lung diffusion capacity major clinical study male multicenter study phenotype prediction randomized controlled trial smoking treatment duration treatment outcome clinical trial drug administration inhalational drug administration lung middle aged pathology pathophysiology physiology placebo effect Pulmonary Disease, Chronic Obstructive severity of illness index spirometry sputum Administration, Inhalation Adrenal Cortex Hormones Aged Bronchodilator Agents Drug Administration Schedule Female Fluticasone Forced Expiratory Volume Humans Lung Male Middle Aged Phenotype Placebo Effect Pulmonary Disease, Chronic Obstructive Severity of Illness Index Spirometry Sputum Treatment Outcome Snoeck-Stroband J.B. Lapperre T.S. Sterk P.J. Hiemstra P.S. Thiadens H.A. Boezen H.M. Ten Hacken N.H.T. Kerstjens H.A.M. Postma D.S. Timens W. Sont J.K. Prediction of long-term benefits of inhaled steroids by phenotypic markers in moderateto-severe COPD: A randomized controlled trial
description	10.1371/journal.pone.0143793
author2	DUKE-NUS MEDICAL SCHOOL
author_facet	DUKE-NUS MEDICAL SCHOOL Snoeck-Stroband J.B. Lapperre T.S. Sterk P.J. Hiemstra P.S. Thiadens H.A. Boezen H.M. Ten Hacken N.H.T. Kerstjens H.A.M. Postma D.S. Timens W. Sont J.K.
format	Article
author	Snoeck-Stroband J.B. Lapperre T.S. Sterk P.J. Hiemstra P.S. Thiadens H.A. Boezen H.M. Ten Hacken N.H.T. Kerstjens H.A.M. Postma D.S. Timens W. Sont J.K.
author_sort	Snoeck-Stroband J.B.
title	Prediction of long-term benefits of inhaled steroids by phenotypic markers in moderateto-severe COPD: A randomized controlled trial
title_short	Prediction of long-term benefits of inhaled steroids by phenotypic markers in moderateto-severe COPD: A randomized controlled trial
title_full	Prediction of long-term benefits of inhaled steroids by phenotypic markers in moderateto-severe COPD: A randomized controlled trial
title_fullStr	Prediction of long-term benefits of inhaled steroids by phenotypic markers in moderateto-severe COPD: A randomized controlled trial
title_full_unstemmed	Prediction of long-term benefits of inhaled steroids by phenotypic markers in moderateto-severe COPD: A randomized controlled trial
title_sort	prediction of long-term benefits of inhaled steroids by phenotypic markers in moderateto-severe copd: a randomized controlled trial
publisher	Public Library of Science
publishDate	2020
url	https://scholarbank.nus.edu.sg/handle/10635/165757
_version_	1781791971575070720

Prediction of long-term benefits of inhaled steroids by phenotypic markers in moderateto-severe COPD: A randomized controlled trial

Similar Items